Synthesis, characterization, molecular docking evaluation, antiplatelet and anticoagulant actions of 1,2,4 triazole hydrazone and sulphonamide novel derivatives
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1752-153X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Synthesis, characterization, molecular docking evaluation, antiplatelet and anticoagulant actions of 1,2,4 triazole hydrazone and sulphonamide novel derivatives ; volume:12 ; number:1 ; day:7 ; month:2 ; year:2018 ; pages:1-16 ; date:12.2018
Chemistry central journal ; 12, Heft 1 (7.2.2018), 1-16, 12.2018
- Creator
-
Khalid, Waseem
- Contributor
-
Badshah, Amir
Khan, Arif-ullah
Nadeem, Humaira
Ahmed, Sagheer
SpringerLink (Online service)
- DOI
-
10.1186/s13065-018-0378-5
- URN
-
urn:nbn:de:101:1-2018090418581113714307
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Khalid, Waseem
- Badshah, Amir
- Khan, Arif-ullah
- Nadeem, Humaira
- Ahmed, Sagheer
- SpringerLink (Online service)
Other Objects (12)
Synthesis, characterization, molecular docking, analgesic, antiplatelet and anticoagulant effects of dibenzylidene ketone derivatives
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
When and How to Combine Antiplatelet and Anticoagulant Drugs?
Biological Control of Combined Treatment by Antiplatelet and Anticoagulant Drugs
Hydrazone.
Pituitary macroadenomas: are combination antiplatelet and anticoagulant therapy contraindicated? A case report
Synthesis and Antimicrobial Activity of Novel Hydrazone and 1,2,4-Triazole-3-thione Derivatives
Effect of anticoagulant/antiplatelet therapy on the development and progression of diabetic retinopathy
Cyclopentadienone-hydrazone
Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients
Synthesis, characterization, molecular docking, analgesic, antiplatelet and anticoagulant effects of dibenzylidene ketone derivatives
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
When and How to Combine Antiplatelet and Anticoagulant Drugs?
Biological Control of Combined Treatment by Antiplatelet and Anticoagulant Drugs
Hydrazone.
Pituitary macroadenomas: are combination antiplatelet and anticoagulant therapy contraindicated? A case report
Synthesis and Antimicrobial Activity of Novel Hydrazone and 1,2,4-Triazole-3-thione Derivatives
Effect of anticoagulant/antiplatelet therapy on the development and progression of diabetic retinopathy
Cyclopentadienone-hydrazone
Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients
Synthesis, characterization, molecular docking, analgesic, antiplatelet and anticoagulant effects of dibenzylidene ketone derivatives
Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
AFM investigation of APAC (antiplatelet and anticoagulant heparin proteoglycan)
When and How to Combine Antiplatelet and Anticoagulant Drugs?
Biological Control of Combined Treatment by Antiplatelet and Anticoagulant Drugs
Hydrazone.
Pituitary macroadenomas: are combination antiplatelet and anticoagulant therapy contraindicated? A case report
Synthesis and Antimicrobial Activity of Novel Hydrazone and 1,2,4-Triazole-3-thione Derivatives
Effect of anticoagulant/antiplatelet therapy on the development and progression of diabetic retinopathy
Cyclopentadienone-hydrazone